Global Biologics and Biosimilars Industry Report 2015-2020
DUBLIN, Mar. 04, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/jspg2c/global_biologics) has announced the addition of the "Global Biologics and Biosimilars Industry Report 2015" report to their offering.
The Global Biologics and Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the biologics and biosimilars industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The biologics and biosimilars market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Biologics and biosimilars industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.
The report focuses on nineteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The biologics and biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 175 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Key Topics Covered:
Chapter One Biologics and Biosimilars Industry Overview
Chapter Two Biologics and Biosimilars International and China Market Analysis
Chapter Three Biologics and Biosimilars Technical Data Analysis 2010-2015
Chapter Four Biologics and Biosimilars Patent Analysis
Chapter Five Biologics and Biosimilars Manufacturing Process and Cost Structure
Chapter Six Biologics and Biosimilars Productions Supply Sales Demand Market Status 2010-2015E
Chapter Seven Biologics and Biosimilar Major Manufacturers Analysis
Chapter Eight Biologics and Biosimilars Industry Chain Structure Analysis
Chapter Nine Biologics and Biosimilars Marketing Channels Analysis
Chapter Ten Biologics and Biosimilars Productions Supply Sales Demand Market Status and Forecast 2015E-2021
Chapter Eleven Paclitaxel Industry Development Proposals
Chapter Twelve Biologics and Biosimilars New Project Investment Feasibility Analysis
Chapter Thirteen Global Biologics and Biosimilars Industry Research Conclusions
Companies Mentioned
- 3Sbio
- Abbvie
- Amgen
- Biotech Pharma
- Cp Guojian Pharmacy
- Changchun High And New Technology Industry (Group) Inc.
- Gelgen Biopharma
- Hospira (Pfizer)
- Johnson & Johnson
- Lilly
- Mylan Inc.
- Merck
- Novartis
- Novo Nordisk
- Pfizer
- Roche
- Sandoz (Novartis)
- Sanofi
- Teva Pharmaceutical Industries
For more information visit http://www.researchandmarkets.com/research/jspg2c/global_biologics
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article